AEROBIC COCCI:GRAM NEGATIVE

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

G- DIPPLOCOCCI (INTRACELLULAR IN GS)

Neisseria GONORRHEAE (GONOCOCCUS)

LEADING CAUSE OF STI

Neisseria GONORRHEAE (GONOCOCCUS)

Neisseria CATALASE

POSITIVE

Neisseria Oxidase

POSITIVE

Neisseria _____________ shape

KIDNEY BEAN

Neisseria motile/Non motile

Non motile

USES SUPER OXOLE TEST (30% H202)

Neisseria

Neisseria Differentiation based on Acid production by _____________

CARBOHYDRATE

Neisseria ____________: Cold,dry, and disinfect and antiseptic

SENSITIVE

Neisseria Fastidious/ Non Fastidious

Fastidious

Neisseria Intracellular or Extracellular

Intracellular or Extracellular

Virulence Factor: a. Capsule: ____________

Neisseria MENINGITIDIS

Virulence Factor: ? : Neisseria MENINGITIDIS

Capsule

Virulence Factor: Pili (fimbriae) ANTIGENS

Neisseria

Neisseria Endotoxin (?)

Lipooligosaccharide

IgA Protease-> CATABOLIZE IGA

Neisseria

Neisseria -> CATABOLIZE IGA

IgA Protease

Neisseria IgA Protease-> CATABOLIZE

CATABOLIZE IGA

venereal disease

Neisseria GONORRHEAE (GONOCOCCUS)

Men – symptomatic

Neisseria GONORRHEAE (GONOCOCCUS)

Neisseria GONORRHEAE (GONOCOCCUS) Men – symptomatic/asymptomatic

symptomatic

Neisseria GONORRHEAE (GONOCOCCUS) Females - symptomatic/asymptomatic, pelvic inflammatory disease –

asymptomatic

GONOCOCCAL ARTHRITIS

Neisseria GONORRHEAE (GONOCOCCUS)

BURNING SENSATION

Neisseria GONORRHEAE (GONOCOCCUS)

BLINDNESS OF A BABY

OPTHALMIA NEONATORUM

OPTHALMIA NEONATORUM CAUSED BY

Neisseria GONORRHEAE (GONOCOCCUS)

OPTHALMIA NEONATORUM PROPYLACTIC AGENT IS

1% SILVER NITRATE

PERIHEPATITIS/

FITZ-HUGH CURTIS

FITZ-HUGH CURTIS /

PERIHEPATITIS

– Mothers birth canal

Ophthalmia neonatorum

Neisseria gonorrhoeae Nutritive Agar

chocolate agar

Neisseria gonorrhoeae Direct microscopic examination-

diplococci

OTHER THAN Neisseria gonorrhoeae Direct microscopic examination- diplococci

C. TRACHOMATIS, UREA PLASMA, UREALYTICUM

N. gonorrhoeae JEMBEC plates STREAK PATTERN

Z SHAPE

Culture of N. gonorrhoeae Subculturing Loses its_______

PILI

Culture of N. gonorrhoeae White candles (?% to ?%) CO

3% to 5%

Neisseria gonorrhoeae (GONOCOCCUS) OPTIMAL GROWTH

35-37oC

Neisseria gonorrhoeae (GONOCOCCUS) CARBOHYDRATE UTILIZATION

GLUCOSE +

Neisseria gonorrhoeae (GONOCOCCUS) RESISTANT TO WHAT ANTIBIOTIC?

PENICILLIN

Neisseria gonorrhoeae (GONOCOCCUS) ? TO PENICILLIN IS DUE TO PRODUCTION OF BETA-LACTAMASE OR ALTERATION PBP

RESISTANT

Neisseria gonorrhoeae (GONOCOCCUS) SWABS MUST BE PLATED WITHIN

6 HOURS

Neisseria gonorrhoeae (GONOCOCCUS) ARE PREFERRED FOR TRANSPORT

CALCIUM ALGINATE/ RAYON FIBERS

SPECIAL MEDIA WITH CO2GENERATING SYSTEM

JEMBEC PLATES

Neisseria gonorrhoeae (GONOCOCCUS) Antimicrobial Resistance:

B LACTAMASE +

: Differentiate some Gram negative rods from Gram Negative Diplococci

Penicillin Test

Procedure: Grow on agar -> Apply Penicillin -> Get from the EDGE of ZOI -> stain and check for _____________

MORPHOLOGY

Procedure: Grow on agar -> Apply Penicillin -> Get from the ___ of ZOI -> stain and check for MORPHOLOGYMORPHOLOGY

EDGE

Kingella and Acinetobacter CHARACTERISTICS

ELONGATE

CHARACTERISTICS ELONGATE (2)

Kingella and Acinetobacter

N.gonorrhoeae Oxidase

N.gonorrhoeae Oxidase + COLOR

PURPLE

N.gonorrhoeae CTA (Cystine trypticase agar): 1% Individual Carb and _____________ as indicator OR ACID PRODUCTION

PHENOL RED

N.gonorrhoeae CTA (Cystine trypticase agar): ____% Individual Carb and PHENOL RED as indicator OR ACID PRODUCTION

N.gonorrhoeae CTA (Cystine trypticase agar): 1% Individual Carb and PHENOL RED as indicator OR ?

ACID PRODUCTION

Carbohydrate Utilization Test: Definitive test Glucose:

N.gonorrhoeae

Carbohydrate Utilization Test: Definitive test : N.gonorrhoeae

Glucose

Carbohydrate Utilization Test: Definitive test Glucose: and Maltose:

N.MENINGITIDIS

Carbohydrate Utilization Test: Definitive test : N.MENINGITIDIS

Glucose and Maltose

Carbohydrate Utilization Test: Definitive test : N.LACTAMICA

Glucose , Maltose AND LACTOSE

Carbohydrate Utilization Test: Definitive test Glucose , Maltose AND LACTOSE:

N.LACTAMICA

Carbohydrate Utilization Test: Definitive test Asaccharolytic:

M. CATARRHALIS

DONT REQUIRE VIABLE ORGANISM; USED WHEN NON LIVING BACTERIA

Nucleic Acid Amplification Tests (NAATs)

Extremely sensitive Test

Nucleic Acid Amplification Tests (NAATs)

Test USED TO Detect both N.gonorrhoeae and C.trachomatis

Nucleic Acid Amplification Tests (NAATs)

Nucleic Acid Amplification Tests (NAATs) USED TO Detect both

N.gonorrhoeae and C.trachomatis

CATALASE POSITIVE PRESUMPTIVE TEST USED FOR N. GONORRHEA

SUPEROXOL (30% H2O2)

SUPEROXOL (30% H2O2) USED FOR WHAT NESSERIA?

N. GONORRHEA

Glucose, Maltose, Sucrose, and Fructose: .

N. SICCA

N. SICCA : .

Glucose, Maltose, Sucrose, and Fructose

DNAse and Nitrate (NO3) reduction:

M. CATARRHALIS

Neisseria meningitides MOT:Resp.droplets WHAT BSL?

BSL 2

Neisseria meningitides MOT:Resp.droplets Diseases

Meningococcemia

Neisseria meningitides DIC -> , AN ADRENAL HEMORRHAGE

WATER HOUSE FRIEDRICHSEN

Direct microscopic examination of CSF - intracellular and extracellular gram-negative diplococci

Neisseria meningitides

Neisseria meningitides Direct microscopic examination of ? - intracellular and extracellular gram-negative diplococci

CSF

____________ swabs are cultured to detect carriers/ RESERVOIRS

NASOPHARYNGEAL

Neisseria meningitides blood and chocolate agar RESULTS ____________

POSITIVE (+)

TEST FOR MALTOSE NEGATIVE STRAIN

y-glutamyl aminopeptidase test

BOTH ARE MALTOSE FERMENTERS

N.meningitidis and N.lactamica

NEISSERIA MENIGITIDIS (MENINGOCOCCUS) CHARACTERISTICS OXIDASE

POSITIVE

NEISSERIA MENIGITIDIS (MENINGOCOCCUS) CHARACTERISTICS CATALASE

POSITIVE

LEADING CAUSE OF BACTERIAL MENINGITIS

NEISSERIA MENIGITIDIS (MENINGOCOCCUS)

NEISSERIA MENIGITIDIS (MENINGOCOCCUS) IS RESISTANT TO WHAT ANTIBIOTIC?

PENICILLIN

FATAL COMPLICATION ASSOCIATED WITH ADRENAL HEMORRHAGE

WATERHOUSE-FRIEDRICHSEN SYNDROME

Treatment a. meningitis:

Penicillin

Treatment a. : Penicillin

meningitis

Treatment :Cephalosporins

meningococcemia

Treatment meningococcemia:

Cephalosporins

Treatment Menactra:

Vaccine

Treatment : Vaccine

Menactra

coccobacillary to bacillary (also part of gram negative nonfermenters)

Moraxella catarrhalis

SEEN IN Upper respiratory tract flora.

Moraxella catarrhalis

Infection: otitis media( ), sinusitis, and respiratory infections.

Moraxella catarrhalis

Infection: otitis media ARE SEEN IN (3)

S PNEUMONIAE HAEMOPHILUS INFLUENZAE B CATARRHALIS

Moraxella catarrhalis Specimen:

MIDDLE EAR ASPIRATE

Moraxella catarrhalis Growth:blood, chocolate, and nutrient agars: APPEARANCE

HOCKEY PUCK AND WAGON WHALE APPEARANCE

Growth:blood, chocolate, and nutrient agars: HOCKEY PUCK AND WAGON WHALE APPEARANCE

Moraxella catarrhalis

Asaccharolytic

Moraxella catarrhalis

Most isolates produce β-lactamase, making them resistant to ampicillin and amoxicillin

Moraxella catarrhalis

100

Moraxella catarrhalis Most isolates produce β-lactamase, making them resistant to ?

ampicillin and amoxicillin

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前